Anikó Égerházi

Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease

Anikó Égerházi, Roland Berecz, Enikő Bartók et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2007 · 210 citations

Neuropsychological Functioning, Neuropsychology, Alzheimer's Disease +9

Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia

György Paragh, Petra Balla, Evelin Katona et al. · European Archives of Psychiatry and Clinical Neuroscience · 2002 · 112 citations

Alzheimer's Disease, Vascular Cognitive Disorder, Dementia +8

Clinical decision making and outcome in the routine care of people with severe mental illness across Europe (CEDAR)

Bernd Puschner, Thomas Becker, Benjamin Mayer et al. · Epidemiology and Psychiatric Sciences · 2015 · 68 citations · Full text

Clinical Decision Making and Outcome in Routine Care for People with Severe Mental Illness (CEDAR): Study protocol

Bernd Puschner, Sabine Steffen, Mike Slade et al. · BMC Psychiatry · 2010 · 49 citations · Full text

N ε (γ-glutamyl)lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia 1 1Abbreviations: AD: Alzheimer dementia, CSF: cerebrospinal fluid, IDP: Nε(γ-glutamyl)lysine isodipeptide, HPLC: high performance liquid chromatography, MMSE: mini-mental state examination

Zoltán Nemes, László Fésüs, Anikó Égerházi et al. · Neurobiology of Aging · 2001 · 48 citations · Full text

Neurodegenerative Diseases, Neurobiology Of Disease, Alzheimer's Disease +14